-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

632.O2.6 632. Chronic Myeloid Leukemia: Clinical and Epidemiological: Alternative Laboratory Predictors of Outcome

Symposia: Chronic Myeloid Leukemia: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Adult, Translational Research, Clinical Practice (Health Services and Quality), CML, Clinical Research, Health outcomes research, Chronic Myeloid Malignancies, Hematopoiesis, Diseases, Immune mechanism, Immunology, Real-world evidence, Biological Processes, Myeloid Malignancies, Molecular biology, Human, Measurable Residual Disease
Monday, December 9, 2024: 4:30 PM-6:00 PM
Seaport Ballroom EFGH (Manchester Grand Hyatt San Diego)
Moderators:
Thomas Ernst, MD, Jena University Hospital and Sarit E. Assouline, MD,
Disclosures:
No relevant conflicts of interest to declare.

This session will address laboratory predictors of response to therapy in chronic myeloid leukemia (CML). In addition to the role of BCR::ABL1 RQ-PCR monitoring, presenters will discuss the impact of mutations in other cancer related genes and the potential prognostic information to be gained from immunophenotyping and profiling, and circulating cytokines.
4:30 PM

Naranie Shanmuganathan, MBBS, PhD, FRACP, FRCPA1,2,3,4, Carol Wadham4*, David T Yeung, MBBS, PhD, BSc, FRACP, FRCPA2,5,6, Nur Hezrin Shahrin4*, Adelina Fernandes7*, Muneeza Maqsood4*, Chung Hoow Kok, PhD, BSc4, Verity A Saunders8*, Ilaria Stefania Pagani, PhD8*, Rosalie Kenyon4*, Ming Lin4*, David M Ross, MD, PhD, FRACP, FRCPA9*, Timothy P Hughes, MD, MBBS, FRACP, FRCPA6 and Susan Branford, PhD10

1Department of Haematology, Central Adelaide Local Health Network, Adelaide, SA, Australia
2Australasian Leukaemia and Lymphoma Group (ALLG), Melbourne, Australia
3South Australian Health and Medical Research Institute, Adelaide, Australia
4Centre for Cancer Biology and SA Pathology, Adelaide, Australia
5Royal Adelaide Hospital, Adelaide, SA, Australia
6South Australian Health and Medical Research Institute, Adelaide, SA, Australia
7University of Adelaide, Adelaide, Australia
8Precision Cancer Medicine Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide, Australia
9Royal Adelaide Hospital and SA Pathology, Adelaide, SA, Australia
10Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia

4:45 PM

Fabio Stagno, MD, PhD1, Rosalba Cucci2*, Giovanni Marsili3*, Fausto Castagnetti, MD, PhD4, Sara Galimberti, MD5*, Barbara Izzo6*, Federica Sorà, MD7*, Simona Soverini, PhD8, Monica Messina, PhD3*, Alfonso Piciocchi3*, Massimiliano Bonifacio, MD9*, Daniela Cilloni, MD10*, Alessandra Iurlo, MD11*, Giovanni Martinelli, M.D.12, Gianantonio Rosti, MD13*, Paola Fazi3*, Marco Vignetti, MD3*, Massimo Breccia14*, Alessandro Allegra, MD1* and Fabrizio Pane15

1Hematology Section, AOU Policlinico "G. Martino", University of Messina, Messina, Italy, Messina, Italy
2GIMEMA Foundation, Roma, Italy
3GIMEMA Foundation, Rome, Italy
4Department of Medical and Surgical Sciences, Institute of Hematology “Seràgnoli”, University of Bologna, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
5Department of Clinical and Experimental Medicine, Hematology, University of Pisa, Pisa, Italy
6Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Napoli, Napoli, Italy
7Institute of Hematology, Policlinico Universitario A. Gemelli, “Cattolica” University, Rome, ROME, Italy
8Department of Medical and Surgical Sciences, Institute of Hematology "L. and A. Seràgnoli", University of Bologna, Castel Maggiore, Bologna, Italy
9Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona, Verona, Italy
10SCDU Hematology and Cellular Therapies, AO Ordine Mauriziano di Torino, Torino, Italy
11Hematology, Foundation IRCCS Ca’Granda Ospedale Maggiore Policlinico, Milan, Italy
12IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy
13IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola (FC), Italy
14Department of Translational and Precision Medicine, Az., Hematology-Sapienza University, Rome, Italy
15Division of Hematology and Bone Marrow Transplantation, Department of Medicine and Surgery University of Naples Federico II, Napoli, Italy

5:00 PM

Chung Hoow Kok, PhD, BSc1,2,3, Verity A Saunders4*, Naranie Shanmuganathan, MBBS, PhD, FRACP, FRCPA5,6,7,8,9,10, Liu Liu11*, Yazad Daruis Irani, BSc, MSc, PhD11,12*, Jade Clarson11*, Phuong Dang4*, David T Yeung, MBBS, PhD, BSc, FRACP, FRCPA13,14,15,16, Agnes S. M. Yong, MD, PhD5,17, Susan Branford, PhD8,18,19, Javier Pinilla-Ibarz, MD, PhD20, Richard A. Larson, MD21, Jorge E. Cortes, MD22, Michael J. Mauro, MD23, James E Thompson, MD24, Neil P. Shah, MD, PhD25, Martha Wadleigh, MD26, Ehab L. Atallah, MD27, Jerald P. Radich, MD28, Timothy P Hughes, MD, MBBS, FRACP, FRCPA13,15,29,30 and David M Ross, MD, PhD, FRACP, FRCPA5,16,31,32,33*

1Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA, Australia
2Centre for Cancer Biology and SA Pathology, Adelaide, Australia
3Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, SA, Australia
4Precision Cancer Medicine Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide, Australia
5South Australian Health and Medical Research Institute, Adelaide, Australia
6Department of Haematology, Royal Adelaide Hospital, Adelaide, SA, Australia
7School of Medicine, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, Australia
8School of Pharmacy and Medical Science, University of South Australia, Adelaide, Australia
9Department of Haematology, Central Adelaide Local Health Network, Adelaide, SA, Australia
10Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia
11Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, Australia
12Department of Anatomical Pathology, Flinders University, Adelaide, Australia
13South Australian Health and Medical Research Institute, Adelaide, SA, Australia
14University of Adelaide, Adelaide, SA, Australia
15Australasian Leukaemia and Lymphoma Group (ALLG), Melbourne, Australia
16Royal Adelaide Hospital, Adelaide, SA, Australia
17Haematology Department, Royal Perth Hospital, Perth, Australia
18SA Pathology, Adelaide, SA, Australia
19Centre for Cancer Biology, Adelaide, Australia
20Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
21Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
22Georgia Cancer Center, Medical College of Georgia, Augusta University, Augusta, GA
23Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, New York, NY
24Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
25University of California San Francisco, San Francisco, CA
26Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
27Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
28Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Rsch. Ctr., Seattle, WA
29Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia
30Department of Haematology and Bone Marrow Transplantation, Royal Adelaide Hospital, Adelaide, Australia
31Royal Adelaide Hospital and SA Pathology, Adelaide, SA, Australia
32Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, Australia
33Department of Haematology, Centre for Cancer Biology, SA Pathology, Adelaide, SA, Australia

5:15 PM

Shaun D. Patterson, PhD, MSc, BSc1*, Isla Nosratzadeh, MSc, BSc1*, Robin Young, PhD2*, Alan Hair, PhD1*, Jennifer Cassels, BSc1*, Richard E. Clark, MBBS, MD, FRCP, FRCPath3*, Heather G Jørgensen, PhD1*, Helen Wheadon, PhD1* and Mhairi Copland, PhD, MBBChir, FRCP, FRCPath1

1School of Cancer Sciences, University of Glasgow, Paul O'Gorman Leukaemia Research Centre, Glasgow, United Kingdom
2Robertson Centre for Biostatistics, University of Glasgow, Glasgow, United Kingdom
3Royal Liverpool University Hospital, Liverpool, United Kingdom

5:30 PM

Anna Sicuranza, PhD1*, Adele Santoni, MD2*, Paola Pacelli3*, Sara Freducci, MD4*, Emanuele Pacini5*, Elisabetta Abruzzese, MD6, Daniele Cattaneo7*, Alessandra Iurlo, MD, PhD8*, Luigiana Luciano, MD9, Sara Galimberti, MD10*, Valentina Giai, MD, PhD11*, Olga Mulas, MD12*, Giovanni Caocci, MD13, Federica Sorà14*, Isabella Capodanno, MD15*, Monica Crugnola, MD16*, Antonella Gozzini, MD17*, Sabina Russo, MD18*, Mario Annunziata, MD19,20*, Claudio Fozza, MD21*, Anna Marina Liberati, MD22, Alessandra Cartocci23*, Elisabetta Zappone24*, Emanuele Cencini, MD25*, Vincenzo Sammartano5*, Elena Bestoso26*, Cristina Marzano27*, Dania Tocci28*, Teresa Miracapillo4*, Camilla Turriziani28*, Donatella Raspadori24* and Monica Bocchia, MD29*

1Hematology, University of Siena, Azienda Ospedaliera Universitaria Senese, Siena, Italy, Siena, Italy
2UOC Ematologia, Azienda ospedaliero-universitaria Senese, Siena, Italy
3Hematology Unit, Department of Medical Science, Surgery and Neuroscience, Univer, Siena, ITA
4Dept of Medical sciences, surgery and neurosciences., Hematoly Unit. University of Siena, Siena, Italy
5University of Siena, Siena, Italy
6Department of Hematology, S. Eugenio Hospital, Tor Vergata University, ASL Roma 2, Roma, I, Italy
7FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO, MILANO, ITA
8Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy
9Hematology Unit, Federico II University, Napoli, Italy
10Department of Clinical and Experimental Medicine, Hematology, University of Pisa, Pisa, Italy
11Hematology, AOU Città della Salute e della Scienza di Torino, Turin, Italy
12Department of Medical Sciences and Public Health, University of Cagliari, Businco Hospital, Cagliari, Italy
13University of Cagliari, Monserrato, Italy
14Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
15Hematology Unit, Azienda Unità Sanitaria Locale-IRCCS, Reggio Emilia, Italy
16Hematology Unit and BMT, University Hospital of Parma, Parma, Italy
17Hematology, AOU Careggi, University of Florence, Florence, Italy
18Division of Hematology, Dipartimento di Patologia Umana dell'Adulto e dell'Età Evolutiva,, Hematology Section, AOU Policlinico "G Martino", University of Messina, Italy, Messina, Italy
19Azienda Ospedaliera Di Rilievo Nazionale Antonio Cardarelli, Napoli, ITA
20Hematology, San Giuseppe Moscati Hospital, Aversa, Italy
21Hematology Unit – Azienda Ospedaliera Universitaria of Sassari, University of Sassari, Sassari, Italy
22A.O. Santa Maria di Terni – Università degli Studi di Perugia, Terni–Perugia, Italy
23Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, ITA
24Hematology Unit, Azienda Ospedaliera Universitaria Senese, Siena, ITA
25Division of Hematology, Azienda Ospedaliera Universitaria Senese & University of Siena, Siena, Italy
26Hematology Unit, University of Siena, Azienda Ospedaliera Universitaria Senese, Siena, Italy, Siena, Italy
27University of Siena, Azienda Ospedaliera Universitaria Senese, Siena, ITA
28Dept of Medical sciences, surgery and neurosciences., Hematoly Unit. University of Siena, Siena, Italy
29Hematology, Azienda Ospedaliera Universitaria Senese, University of Siena, Siena, Italy

5:45 PM

Susan Branford, PhD1, Adelina Fernandes2*, Carol Wadham3*, Muneeza Maqsood3*, Nur Hezrin Shahrin3*, David M Ross, MD, PhD, FRACP, FRCPA4*, Agnes S. M. Yong, MD, PhD5, Ming Lin3*, Rosalie Kenyon3*, Dominik Kaczorowski6*, Verity A Saunders7*, Ilaria Stefania Pagani, PhD8*, John Toubia9*, Joe McConnell3*, David T Yeung, MBBS, PhD, BSc, FRACP, FRCPA10, Chung Hoow Kok, PhD, BSc3, Timothy P Hughes, MD, MBBS, FRACP, FRCPA7 and Naranie Shanmuganathan, MBBS, PhD, FRACP, FRCPA11

1Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia
2University of Adelaide, Adelaide, Australia
3Centre for Cancer Biology and SA Pathology, Adelaide, Australia
4Royal Adelaide Hospital and SA Pathology, Adelaide, SA, Australia
5South Australian Health and Medical Research Institute, Adelaide, Australia
6SA Pathology and Centre for Cancer Biology, Adelaide, Australia
7Precision Cancer Medicine Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide, Australia
8South Australian Health & Medical Research Institute (SAHMRI), Adelaide, AUS
9Centre For Cancer Biology, Adelaide, AUS
10South Australian Health and Medical Research Institute, Adelaide, SA, Australia
11Department of Haematology, Central Adelaide Local Health Network, Adelaide, SA, Australia

*signifies non-member of ASH